RT @drpnash: Integrated Safety of Filgotinib in Patients with Moderately or Severely Active Rheumatoid Arthritis Receivi

Social Author Image
https://pbs.twimg.com/profile_images/1702756729/image.jpg
Tweet Author
drpnash
Social Author Name
Peter Nash
Tweet Content
Integrated Safety of Filgotinib in Patients with Moderately or Severely Active Rheumatoid Arthritis Receiving Treatment for up to 5.5 Years https://t.co/9YNEGXKoAD #RA #filgotinib low vte & low zoster rates
Links
Integrated Safety of Filgotinib in Patients with Moderately or Severely Active … https://acrabstracts.org/abstract/integrated-safety-of-filgotinib-in-patients-w…
Show on Archive Page
On
Display in Search Results
On

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.

×